Smoking Cessation Growth Opportunities Lay With Employers, Health Care Reform
This article was originally published in The Tan Sheet
Executive Summary
Many employers still hold a short-sighted view of the cost of smoking cessation therapies, panelists at an American University webinar said Nov. 16.
You may also be interested in...
Advisory Committee On NRT Indications Appears Likely Following Workshop
Speakers at a workshop on nicotine-replacement therapy point abroad for guidance on expanding indications for smoking-cessation products as an FDA official says the agency likely will put the question before an advisory committee.
Smoking Cessation Savings Outweigh Costs Of Subsidies - Study
A 1study showing that the financial benefits of government subsidies for smoking cessation programs outweigh their costs prompts advocates and researchers to urge Medicaid coverage for the products, which could boost product sales
NRT Petition Calls On FDA To Greatly Expand Indications, Availability
FDA's stated commitment to a public health approach to drug regulation will be put to the test by a petition to expand nicotine replacement therapy indications and availability
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: